DE69713611D1 - Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie - Google Patents

Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie

Info

Publication number
DE69713611D1
DE69713611D1 DE69713611T DE69713611T DE69713611D1 DE 69713611 D1 DE69713611 D1 DE 69713611D1 DE 69713611 T DE69713611 T DE 69713611T DE 69713611 T DE69713611 T DE 69713611T DE 69713611 D1 DE69713611 D1 DE 69713611D1
Authority
DE
Germany
Prior art keywords
pct
tissues
mercaptoethanesulfonate
sodium
surgery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69713611T
Other languages
English (en)
Other versions
DE69713611T2 (de
Inventor
Carlo Zini
Salvatore Bacciu
Angelo Gandolfi
Fabio Piazza
Enrico Pasanisi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A R D O ASSOCIAZIONE RICERCA E
Original Assignee
A R D O ASSOCIAZIONE RICERCA E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A R D O ASSOCIAZIONE RICERCA E filed Critical A R D O ASSOCIAZIONE RICERCA E
Application granted granted Critical
Publication of DE69713611D1 publication Critical patent/DE69713611D1/de
Publication of DE69713611T2 publication Critical patent/DE69713611T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DE69713611T 1996-10-11 1997-10-07 Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie Expired - Lifetime DE69713611T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002117A IT1284973B1 (it) 1996-10-11 1996-10-11 Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
PCT/EP1997/005485 WO1998016213A1 (en) 1996-10-11 1997-10-07 Use of sodium 2-mercaptoethanesulfonate in surgery

Publications (2)

Publication Number Publication Date
DE69713611D1 true DE69713611D1 (de) 2002-08-01
DE69713611T2 DE69713611T2 (de) 2003-01-30

Family

ID=11375023

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69713611T Expired - Lifetime DE69713611T2 (de) 1996-10-11 1997-10-07 Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie

Country Status (9)

Country Link
US (1) US6143797A (de)
EP (1) EP0930878B1 (de)
JP (1) JP4208967B2 (de)
AT (1) ATE219668T1 (de)
AU (1) AU4707797A (de)
DE (1) DE69713611T2 (de)
ES (1) ES2178760T3 (de)
IT (1) IT1284973B1 (de)
WO (1) WO1998016213A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030175A1 (it) * 2003-02-04 2004-08-05 Giorgio Conti Uso del 2-mercaptoetansolfonato di sodio come agente antivirale
KR20070089222A (ko) * 2004-12-10 2007-08-30 알콘, 인코퍼레이티드 귀 감염을 치료하기 위한 조성물
AU2014349663A1 (en) 2013-11-17 2016-06-02 Rdd Pharma Ltd. Methods for treating radiation induced gastrointestinal tract injury
EP3999047A1 (de) 2019-07-19 2022-05-25 AuXin Surgery SA Mesna-zusammensetzung, kit mit mesna und verfahren zur visualisierung einer auf gewebe aufgebrachten mesna-zusammensetzung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244920A (en) * 1985-04-15 1993-09-14 Schering Spa Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic arginine salt
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
DE4233842A1 (de) * 1992-10-08 1994-04-14 Asta Medica Ag Mesna Injektionslösungen
US5661188A (en) * 1995-06-07 1997-08-26 Medical Research Foundation and Infrastructure Development for Health Services--Nahariya Hospital Branch Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)

Also Published As

Publication number Publication date
ATE219668T1 (de) 2002-07-15
IT1284973B1 (it) 1998-05-28
WO1998016213A1 (en) 1998-04-23
EP0930878B1 (de) 2002-06-26
ITMI962117A1 (it) 1998-04-11
DE69713611T2 (de) 2003-01-30
US6143797A (en) 2000-11-07
ES2178760T3 (es) 2003-01-01
JP4208967B2 (ja) 2009-01-14
EP0930878A1 (de) 1999-07-28
JP2001508033A (ja) 2001-06-19
AU4707797A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
ATE317262T1 (de) Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion
ATE300597T1 (de) Behandlung von geweben
DK1140969T3 (da) Bindevævsvækstfaktorfragmenter og fremgangsmåder og anvendelser deraf
ATE282423T1 (de) Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ID21927A (id) Asam aminoalkanafosfonat tersubstitusi
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
DE69839696D1 (de) Anellierte dihydropyrane
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
DE69838509D1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
DE69713611D1 (de) Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
PT1152757E (pt) Inibidores de mmp no amolecimento do tecido conjuntivo
BR0113147A (pt) Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos
ATE375152T1 (de) Behandlung von gastrointestinalen erkrankungen mit n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2- amine
DE69724944D1 (de) Peptidverbindungen mit mmp- und tnf-hemmender wirkung
ATE278407T1 (de) Verwendung von d-galaktose zur verhinderung von nekrosen
DE69626010T2 (de) Verwendung von tropolon derivate zur hemmung des inositmono phosphatase
ATE313329T1 (de) Disaccharidderivate zur behandlung von hyperglykämien